Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Chinese Patent Office
Colorcon
Fish and Richardson
Fuji
Queensland Health
QuintilesIMS
Federal Trade Commission
Citi

Generated: September 23, 2018

DrugPatentWatch Database Preview

Solopak Company Profile

« Back to Dashboard

What is the competitive landscape for SOLOPAK, and what generic and branded alternatives to SOLOPAK drugs are available?

SOLOPAK has thirty-three approved drugs.



Summary for Solopak
US Patents:0
Tradenames:16
Ingredients:15
NDAs:33

Drugs and US Patents for Solopak

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solopak HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride INJECTABLE;INJECTION 086822-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Solopak HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride INJECTABLE;INJECTION 088517-001 Aug 22, 1985 DISCN No No ➤ Sign Up ➤ Sign Up
Solopak CLINDAMYCIN PHOSPHATE clindamycin phosphate INJECTABLE;INJECTION 062852-001 Mar 17, 1988 DISCN No No ➤ Sign Up ➤ Sign Up
Solopak NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 071672-001 Nov 17, 1987 DISCN No No ➤ Sign Up ➤ Sign Up
Solopak HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride INJECTABLE;INJECTION 087595-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Julphar
Healthtrust
US Department of Justice
Covington
Federal Trade Commission
Mallinckrodt
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.